In Vitro Activity of Tea Tree Oil Vaginal Suppositories against Candida spp. and Probiotic Vaginal Microbiota

2015 ◽  
Vol 29 (10) ◽  
pp. 1628-1633 ◽  
Author(s):  
Maura Di Vito ◽  
Paola Mattarelli ◽  
Monica Modesto ◽  
Antonietta Girolamo ◽  
Milva Ballardini ◽  
...  
Keyword(s):  
Vaginal Microbiota ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Tea Tree Oil ◽  
Candida Spp ◽  
Tea Tree

scholarly journals In Vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells

2015 ◽  
Vol 53 (3) ◽  
pp. 285-294 ◽  
Author(s):  
Diane C. Homeyer ◽  
Carlos J. Sanchez ◽  
Katrin Mende ◽  
Miriam L. Beckius ◽  
Clinton K. Murray ◽  
...  
Keyword(s):  
Filamentous Fungi ◽  
Human Cells ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Tea Tree Oil ◽  
Melaleuca Alternifolia ◽  
Tea Tree

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

1999 ◽  
Vol 44 (5) ◽  
pp. 697-700 ◽  
Author(s):  
M. Chávez ◽  
S. Bernal ◽  
A. Valverde ◽  
M. J. Gutierrez ◽  
G. Quindós ◽  
...  
Keyword(s):  
Antifungal Agents ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Candida Spp ◽  
Oral Candida

scholarly journals In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis

2017 ◽  
Vol 72 (5) ◽  
pp. 1355-1358 ◽  
Author(s):  
Dina A. Boikov ◽  
Jeffrey B. Locke ◽  
Kenneth D. James ◽  
Ken Bartizal ◽  
Jack D. Sobel
Keyword(s):  
Vulvovaginal Candidiasis ◽  
Vitro Activity ◽  
The Novel ◽  
In Vitro Activity ◽  
Candida Spp

In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.

2017 ◽  
Vol 50 (1) ◽  
pp. 47-54
Author(s):  
George Tetz ◽  
Michael Cynamon ◽  
Gregory Hendricks ◽  
Daria Vikina ◽  
Victor Tetz
Keyword(s):  
Vitro Activity ◽  
In Vitro Activity ◽  
Candida Spp ◽  
Clinically Significant

In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.

1996 ◽  
Vol 40 (9) ◽  
pp. 2229-2231 ◽  
Author(s):  
H M Wardle ◽  
D Law ◽  
D W Denning
Keyword(s):  
High Resolution ◽  
Amphotericin B ◽  
Clinical Studies ◽  
Antifungal Agents ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Candida Spp ◽  
New Class ◽  
Microdilution Method

We compared the in vitro activity of BMS-181184, the first compound of a new class of antifungal agents, the pradimicins, with those of fluconazole and amphotericin B against 64 clinical isolates of Candida species. MICs were determined by a microdilution method with high resolution medium for BMS-181184 and fluconazole and antibiotic medium no. 3 with 2% glucose for amphotericin B. MICs of BMS-181184 for all yeasts were in the range of 0.78 to 12.5 micrograms/ml. BMS-181184 was active against isolates resistant to other antifungal agents, consistent with a novel mode of action. Minimum fungicidal concentrations for 16 isolates showed that BMS-181184 was fungicidal. Clinical studies are now required to confirm its activity.

Sign in / Sign up

Export Citation Format

Share Document